UT Health San Antonio (Long School of Medicine)
Internal Medicine residency · San Antonio, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas at San Antonio Health Science Center's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About The University of Texas at San Antonio Health Science Centerinstitution-wide internal medicine research
Internal Medicine publications from The University of Texas at San Antonio Health Science Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
451
works per year
58th of 129 internal medicine residency programs
+12.7%
2-year growth
44th of 129 internal medicine residency programs
27.2%
in top 10% of field (works before 2025)
38th of 120 internal medicine residency programs
46.6%
cited above world average
51st of 120 internal medicine residency programs
Works per year · * 2026 so far
Pulmonary and Respiratory Medicine · 413Oncology · 374Cardiology and Cardiovascular Medicine · 274Infectious Diseases · 242Endocrinology, Diabetes and Metabolism · 229
Internal Medicine research topics at The University of Texas at San Antonio Health Science Center
Papers in the window; each links to the list on OpenAlex.
- Antifungal resistance and susceptibility 68
- Cancer Immunotherapy and Biomarkers 66
- Chronic Kidney Disease and Diabetes 59
- Diabetes Treatment and Management 58
- Sarcoma Diagnosis and Treatment 51
- Trauma, Hemostasis, Coagulopathy, Resuscitation 47
- Ultrasound in Clinical Applications 46
- Cancer survivorship and care 42
Most cited at The University of Texas at San Antonio Health Science Center since 2024
All internal medicine papers there on OpenAlex
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber et al. · The Lancet · 2024 · PubMed · cited 958
- Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Patrick Barry Mark et al. · The Lancet · 2025 · PubMed · cited 587
- A Phase 2 Randomized Trial of Survodutide in MASH and FibrosisArun Jayant Sanyal et al. · New England Journal of Medicine · 2024 · PubMed · cited 536
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASMOliver A. Cornely et al. · The Lancet Infectious Diseases · 2025 · PubMed · cited 444
- Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M. Younossi et al. · Gastroenterology · 2025 · PubMed · cited 203
- International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetesMichael Bergman et al. · Diabetes Research and Clinical Practice · 2024 · PubMed · cited 183
- Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal diseaseMartin Hoenigl et al. · Clinical Microbiology Reviews · 2024 · PubMed · cited 160
- Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trialAndrea J. Bullock et al. · Nature Medicine · 2024 · PubMed · cited 159
- SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam Grippin et al. · Nature · 2025 · PubMed · cited 151
- Prognostic Value of Cardiovascular Biomarkers in the PopulationFranz–Josef Neumann et al. · JAMA · 2024 · PubMed · cited 127